Home » Authors » Tiffany Turner

Articles by Tiffany Turner

Middlebrook Gets $100M and a New Management Team

Nov. 1, 2011

By Tiffany Turner

No Abstract

IDM Pleased with Data from Osteosarcoma Program

Nov. 1, 2011

By Tiffany Turner

No Abstract

LigoCyte Sets Series C Terms: $28M for Vaccine Development

Nov. 1, 2011

By Tiffany Turner

No Abstract

NewCo News: Cortria Aims to Capitalize on Dyslipidemia Market

July 21, 2008

By Tiffany Turner

BioAlliance Stops Doxorubicin Trial After Pulmonary Reactions

July 17, 2008

By Tiffany Turner

Avastin, Tarceva Sales Boost Genentech's Quarterly Earnings

July 16, 2008

By Tiffany Turner

Neurogen Halts Dosing of Adipiplon in Insomnia

July 15, 2008

By Tiffany Turner

Big Pharmas Team Up to Link Technology and Business Needs

July 11, 2008

By Tiffany Turner

SGX Shares Soar on Merger Giving Lilly Technology Boost

July 10, 2008

By Tiffany Turner

Seattle Genetics Nets $4M in Deal with Daiichi Sankyo

July 9, 2008

By Tiffany Turner

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...